Dosing begins in phase I/II study of TP-0184 as treatment of anemia in patients with MDS Jan. 20, 2021
BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia Jan. 19, 2021
RSS